Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 1 | uM | 9 | 5000.00 | 2808.68 | 7376.00 | 7049.00 | 1.0464 | 1.0695 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 6980.00 | 7049.00 | 0.9902 | 0.9852 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 6723.00 | 7049.00 | 0.9538 | 0.9299 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 5000.00 | 2808.68 | 7060.00 | 7049.00 | 1.0016 | 1.0024 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 6808.00 | 7049.00 | 0.9658 | 0.9483 | |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 5000.00 | 2808.68 | 6847.00 | 7049.00 | 0.9713 | 0.9567 |
| BT-20 | Erlotinib | 10 | uM | 9 | 5000.00 | 2808.68 | 3996.00 | 7049.00 | 0.5669 | 0.3042 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 5000.00 | 2808.68 | 6709.00 | 7049.00 | 0.9518 | 0.9269 |
| BT-20 | Lapatinib | 10 | uM | 9 | 5000.00 | 2808.68 | 3654.00 | 7049.00 | 0.5184 | 0.2192 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 6796.00 | 7049.00 | 0.9641 | 0.9457 | |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7191.00 | 7049.00 | 1.0201 | 1.0303 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 5000.00 | 2808.68 | 7164.00 | 7049.00 | 1.0163 | 1.0245 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 6966.00 | 7049.00 | 0.9882 | 0.9822 | |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7096.00 | 7049.00 | 1.0067 | 1.0100 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 6967.00 | 7049.00 | 0.9884 | 0.9825 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 4958.00 | 7049.00 | 0.7034 | 0.5343 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 2414.00 | 7049.00 | 0.3425 | -0.1078 |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 5000.00 | 2808.68 | 4486.00 | 7049.00 | 0.6364 | 0.4229 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 7150.00 | 7049.00 | 1.0143 | 1.0215 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 7039.00 | 7049.00 | 0.9986 | 0.9979 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 7004.00 | 7049.00 | 0.9936 | 0.9904 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 4760.00 | 7049.00 | 0.6753 | 0.4879 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 7090.00 | 7049.00 | 1.0058 | 1.0088 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 6274.00 | 7049.00 | 0.8901 | 0.8320 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 7451.00 | 7049.00 | 1.0570 | 1.0853 |